Healthtech Startups

2070 Health is a venture studio that builds and incubates new healthcare companies, working to launch ventures and recruit founders to scale them. It operates across new ventures, investments, and company incubation in the healthcare sector.

1 investor

20n uses machine learning and computational biology to predict DNA sequences for industrial biotech and pharmaceutical applications. The company serves manufacturing firms developing biologically-based alternatives to traditional chemical production of fuels, materials, therapeutics, and specialty chemicals.

1 investor

23Strands works in precision medicine and genomics, and has launched Geneve Health Pty Ltd, a wholly owned entity focused on precision medicine for women's and reproductive health. The company aims to provide healthcare tailored to individual patients.

1 investor

2508 Biosciences develops therapeutics for the treatment of traumatic brain injury.

1 investor

2bull MeDiTherapy develops in-vitro diagnostic medical devices, including TAP, a blood test designed to detect thoracic and abdominal aortic aneurysms. The company focuses on early detection and monitoring diagnostics for cardiovascular disease.

1 investor

1 investor

2cureX develops IndiTreat®, a 3D functional precision medicine test that grows patient-derived cancer cells as 3D microtumors (tumoroids) from a tumor biopsy to profile drug sensitivity and guide individualized therapy selection. The company serves oncologists and healthcare professionals, providing drug-response reports to inform cancer treatment decisions, and brings its diagnostic products through EU regulatory and reimbursement pathways.

1 investor

2EyesVision develops ophthalmic simulation technology for patients to experience presbyopic and cataract corrections before surgery. The company commercializes medical devices and software solutions addressing age-related vision conditions affecting large patient populations globally.

1 investor

A biotech company focused on microbiome and metabolomics research for gastrointestinal health applications, with leadership and scientific advisory rooted in academic medicine and regulatory expertise.

1 investor

NuvemRx (340 Basics) provides 340B pharmacy program services for community health centers and healthcare providers across the U.S., including third-party administration for contract pharmacies, entity-owned pharmacy setup and optimization, and specialty referral management. It combines software, data insights, and pharmacy experts to help providers manage compliance, capture eligible savings, and run their pharmacy programs.

1 investor

360 Health Technologies builds human-centered digital health and wellness platforms, combining psychology, technology, medication, and coaching. Its products include MIRA Health, an insulin-resistance and lifestyle app, and MyNutriPro, a content and client management platform for health practitioners, along with custom app development and API integration services.

1 investor

360 Physical Therapy offers physical therapy services including orthopedic rehabilitation, sports injury treatment, and personalized recovery programs. It operates across Arizona and Oklahoma in the United States.

1 investor

1 investor

The site publishes real-time football (soccer) betting odds, match schedules, results, and expert analysis aggregated from bookmakers, covering leagues such as the Premier League, La Liga, Champions League, and V-League. It targets Vietnamese-language sports bettors and football fans.

1 investor

3billion provides genetic diagnostic services for rare diseases, using automated reanalysis and clinical review to increase diagnostic yield for healthcare providers and institutions. It works with providers across more than 70 countries.

1 investor

3D OrthoBiologic Solutions develops and commercializes 3D-printed bone graft scaffolds for surgery and 3D cell culture technologies, targeting the treatment of bone defects and diseases. Its work focuses on orthopedic and oral/maxillofacial reconstructive and regenerative medicine.

1 investor

3Helix develops and sells collagen hybridizing peptides (CHP) and related conjugates for research and diagnostic applications. The company's products are designed to detect and bind denatured collagen chains in both laboratory and in vivo settings.

1 investor

3PBIOVIAN is a global Contract Development and Manufacturing Organization (CDMO) providing end-to-end biopharmaceutical manufacturing services for biotech and pharma companies. The company offers microbial and mammalian protein expression, viral vector production, cell therapy, plasmid DNA production, and fill & finish services across multiple locations in Spain, Finland, and the United States.

1 investor

3X4 Genetics provides direct-to-consumer genetic testing and personalized health recommendations based on DNA analysis, focusing on nutrient needs, disease prevention, weight management, and stress response. The company delivers actionable insights through a mobile app and optional practitioner consultations in the digital health and wellness sectors.

1 investor

3Y Health provides business setup and compliance infrastructure for healthcare practitioners, handling licensing, registration, and regulatory requirements so practitioners can launch their practice with minimal administrative burden.

1 investor

48Hour Discovery is a drug discovery company using chemically modified phage display technology to identify peptide leads with high affinity and specificity. It serves pharmaceutical companies and startups, taking peptide discovery projects from inception through synthesis, validation, and optimization for a range of protein and cell-based targets.

1 investor

4B Tech develops therapeutics for central nervous system and neurodegenerative diseases, focusing on neuroprotection, synaptic repair, and suppression of neuroinflammation to slow disease progression. Its approach targets the underlying pathophysiology of neural degeneration rather than specific disease causes.

1 investor

4Blind develops assistive hardware for blind and deafblind people, including the Braille Glove and HaptiBraille Communicator, a tactile pad for schools and universities, and a smart charging adapter. Its devices aim to enable communication and greater independence for deafblind individuals.

1 investor

4C Medical develops minimally invasive medical devices for structural heart disease, including mitral and tricuspid valve treatments. The company serves interventional cardiologists and patients requiring catheter-based cardiac interventions.

1 investor